PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Diflucortolone valerate
Presentation Product Chemical substance Chapter Items dispensed
Nerisone Forte 0.3% oily cream
1304000L0BBACAC
Nerisone Diflucortolone valerate Skin 147
Nerisone 0.1% oily cream
1304000L0BBABAB
Nerisone Diflucortolone valerate Skin 110
Nerisone 0.1% cream
1304000L0BBAAAA
Nerisone Diflucortolone valerate Skin 57
Diflucortolone 0.1% cream
1304000L0AAAAAA
Diflucortolone valerate Diflucortolone valerate Skin 48
Diflucortolone 0.3% oily cream
1304000L0AAACAC
Diflucortolone valerate Diflucortolone valerate Skin 44
Diflucortolone 0.1% oily cream
1304000L0AAABAB
Diflucortolone valerate Diflucortolone valerate Skin 43
Nerisone Forte 0.3% ointment
1304000L0BBAEBC
Nerisone Diflucortolone valerate Skin 28
Nerisone 0.1% ointment
1304000L0BBADBB
Nerisone Diflucortolone valerate Skin 19
Diflucortolone 0.3% ointment
1304000L0AABCBC
Diflucortolone valerate Diflucortolone valerate Skin 12
Diflucortolone 0.1% ointment
1304000L0AABBBB
Diflucortolone valerate Diflucortolone valerate Skin 11

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.